NIH

Trial By Error: Interview with Journalist Betsy Ladyzhets about NIH’s Flawed $1.2 Billion RECOVER Program for Long Covid

By David Tuller, DrPH Betsy Ladyzhets is an independent health, science and data journalist who has been covering the coronavirus pandemic, including long Covid. While serving as a journalism fellow at MuckRock, she co-wrote an investigative report for STAT, a well-known health and medical news site, about the US National Institutes of Health’s problem-plagued $1.2 …

Trial By Error: Interview with Journalist Betsy Ladyzhets about NIH’s Flawed $1.2 Billion RECOVER Program for Long Covid Read More »

Trial By Error: Why Did the NIH List an Award for Research on Cancer-Related Fatigue in Its List of Spending on ME/CFS?

By David Tuller, DrPH*April is crowdfunding month at UC Berkeley. If you like my work, consider making a tax-deductible donation to Berkeley’s School of Public Health to support the Trial By Error project:  https://crowdfund.berkeley.edu/project/37217 Each year, the US National Institutes of Health publishes its “estimates of funding for various research, condition, and disease categories.” These estimates …

Trial By Error: Why Did the NIH List an Award for Research on Cancer-Related Fatigue in Its List of Spending on ME/CFS? Read More »

Trial By Error: Jennie Spotila’s Annual Fact-Check of NIH Spending on ME/CFS Research

By David Tuller, DrPH There is a lot going on in the ME and ME/CFS world that I don’t get around to. That’s why I’m always grateful that Jennie Spotila always deconstructs the numbers on the annual spending claims from the National Institutes of Health. Last month, on her blog Occupy M.E., Spotila submitted the …

Trial By Error: Jennie Spotila’s Annual Fact-Check of NIH Spending on ME/CFS Research Read More »

Can the big ship NIH turn at all?

The National Institutes of Health is the major funding agency for biomedical research in the United States. Nevertheless, there are shocking disparities in grant awards for investigators according to race, gender, age, institution, and state. Such unbalanced allocations must be corrected as they do not encourage the varied perspectives, creative ideas and experimental approaches that …

Can the big ship NIH turn at all? Read More »

TWiV 335: Ebola lite

On episode #335 of the science show This Week in Virology, the TWiVumvirate discusses a whole Ebolavirus vaccine that protects primates, the finding that Ebolavirus is not undergoing rapid evolution, and a proposal to increase the pool of life science researchers by cutting money and time from grants. You can find TWiV #335 at www.microbe.tv/twiv.

Scroll to Top